Evidence map›Paper›PMID 39420974›Full record

ArticleCardiology research2024

Evaluating the Prognostic Value of the Modified H

Ya Qiong Jin, Lu Geng, Yue Li, Ke Ke Wang, Bing Xiao, Meng Xiao Wang, Xue Ying Gao, Jie Zhang, Xiu Chun Yang, Jing Chao Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Discordance Between HJournal of clinical practice and research · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ya Qiong JinDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Lu GengDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Yue LiDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Ke Ke WangDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Bing XiaoDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Meng Xiao WangDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Xue Ying GaoDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Jie ZhangDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Xiu Chun YangDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.
Jing Chao LuDepartment of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei 050000, China.ORCID https://orcid.org/0000-0002-6946-0086

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The H Methods: In this retrospective study, we calculated the H Results: Over a mean follow-up of 40.46 ± 6.52 months, the primary and secondary endpoints occurred in 168 patients (33.8%) and 97 patients (19.5%), respectively. By the definition of obesity as BMI ≥ 25 kg/m Conclusions: The modified H

Indexed as

Acute coronary syndromeCardiovascular eventsHeart failureHeart failure with preserved ejection fractionRisk stratification

Identifiers

PMID39420974
PMCPMC11483114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.